In Vivo Multi-Material Bioprinting with Single Printhead

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current bioprinting technologies are limited to using a single bioink at a time, making the process time-consuming and requiring invasive surgical procedures for implanting biomedical constructs, which are risky and have long recovery times.

Innovation Solution

A multi-material bioprinter with a single printhead connected to multiple bioink reservoirs, allowing for rapid and minimally invasive in vivo bioprinting by quickly switching between different bioinks using a programmable pneumatic system, enabling the fabrication of complex biomedical constructs.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Device complexity

If a single bioink is used at a time in bioprinting, then the bioprinting process can be simplified, but the fabrication time increases significantly and multiple separate procedures are required

Engineering Contradiction:
Improvebioprinting system complexityVSAvoidbiomedical construct fabrication speed
Core Design Contradiction:
Device complexityVSProductivity

Solution Approach 1:

The patent combines multiple bioink delivery systems into a single integrated printhead assembly. The multi-channel printhead allows simultaneous or sequential deposition of different bioinks in one continuous printing operation, eliminating the need for multiple separate bioprinting procedures and significantly reducing fabrication time while maintaining manageable system complexity through unified control

Inventive Principle:
Principle #5Merging (Combining)

2Manufacturing precision

If biomedical constructs are fabricated outside the body and then implanted, then the constructs can be pre-manufactured with controlled properties, but invasive surgical procedures are required which carry high infection risk and long recovery time

Engineering Contradiction:
Improveconstruct microarchitecture controlVSAvoidsurgical infection risk
Core Design Contradiction:
Manufacturing precisionVSObject-affected harmful factors

Solution Approach 1:

The patent transitions from external fabrication followed by implantation to direct in vivo fabrication. The bioprinter is introduced through a minimally invasive catheter into the body cavity, enabling construction of biomedical implants directly at the target site within the body. This dimensional shift from extracorporeal to intracorporeal manufacturing eliminates open surgical procedures while maintaining manufacturing precision through controlled bioink deposition

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Solution Approach 2:

The patent uses a catheter-based delivery system as an intermediary to introduce the bioprinting apparatus into the body through minimally invasive keyhole cuts. This intermediary device enables the transition from invasive surgical implantation to minimally invasive in vivo fabrication, reducing infection risk and recovery time while allowing precise construct formation at the target site

Inventive Principle:
Principle #24Intermediary (Mediator)

3Adaptability or versatility

If multiple bioinks are used to create complex biomedical constructs, then the functional capabilities and structural complexity increase, but the bioprinting process becomes more complex and time-consuming

Engineering Contradiction:
Improvebiomedical construct functionalityVSAvoidmulti-material bioprinting system complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent segments the bioink delivery system into multiple independent channels within a single printhead, with each channel capable of delivering a different bioink. This segmentation allows complex multi-material constructs to be fabricated by selectively activating different channels, managing material diversity through modular channel design rather than requiring separate printheads for each material

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent creates a universal printhead system that can handle multiple different bioinks through a single multi-channel device. The printhead is designed with universal compatibility for various bioink types, allowing the same device to perform multiple material deposition functions. This multi-functionality reduces overall system complexity compared to having separate specialized printheads for each bioink type

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS12103173B2Systems and methods for in vivo multi-material bioprinting
Publication Date: 2024.10.01 THE BRIGHAM & WOMEN S HOSPITAL INC
  • US12103173B2 patent drawing
  • US12103173B2 patent drawing
  • US12103173B2 patent drawing

AI summary

Described are systems and methods for in vivo multi-material bioprinting. The in vivo multi-material bioprinting can be used to fabricate biomedical constructs within a patient minimally invasively. The systems and methods can utilize a multi-material bioprinter, which includes a biocompatible portion. The biocompatible portion can include a single printhead for in vivo bioprinting. The single printhead can include a plurality of outlets, each linked to one of a plurality of reservoirs. Each of the plurality of reservoirs can each house a different bioink for bioprinting. Each of the plurality of outlets can be activated to release a respective bioink.